News & Updates

New Funding Supports Research on COVID-19 and Breast and Cervical Cancer

January 22, 2021

New Funding Supports Research on COVID-19 and Breast and Cervical Cancer

Washington, DC - The Institute for Medicaid Innovation (IMI), a non-profit, nonpartisan research organization, has been awarded funding from the American Cancer Society Cancer Action Network (ACS CAN) to launch a new research study to explore the impact of COVID-19 on income loss, loss of health insurance, or both and the effect this may have on the number of individuals who are eligible for the national Breast and Cervical Cancer Early Detection Program (BCCEDP).

BCCEDP supports efforts to increase access to breast and cervical cancer screening, diagnostic, and treatment services for low-income, uninsured, and underinsured individuals.  Additionally, the program allows states to offer treatment to individuals who are diagnosed with cancer through Medicaid programs. As states consider how to balance their budgets in response to shortfalls resulting from the COVID-19 pandemic, there is concern that funds allocated for the Medicaid program could be diverted away from essential women’s health programs. This disinvestment could impact access to care for the growing population of individuals with low incomes and inadequate health insurance.

Through funding from ACS CAN, IMI will investigate how job loss, income loss, and/or loss of insurance due to COVID-19 has impacted the number and percent of individuals who are eligibile for BCCEDP programming. The results of the analyses will help inform critical decisions and opportunities around investing in BCCEDP for the Medicaid population. IMI looks forward to conducting this important research.  


About the Institute for Medicaid Innovation

The Institute for Medicaid Innovation (IMI) is a 501(c)3 nonprofit, nonpartisan research and policy organization that provides independent, nonpartisan information and analysis that informs Medicaid policy and improves the health of the nation.


Media Contact

Lydia Tonkonow